Sandro C Esteves

No ORCID on file · 20 papers in corpus · active 2011-2026

Study types

  • other 3
  • review 2
  • book 1

Condition tags

  • endometriosis 2
  • infertility 2
other 2026
Gynecologic and obstetric investigation ·doi:10.1159/000550420

INTRODUCTION: Investigation of the number of oocytes recovered from different ovarian stimulation (OS) protocols is essential, as oocyte number is positively associated with the number of good-quality embryos obtained; however, there are fe…

2026
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deaf212

Study questionWhat is the recommended prevention, diagnosis, and treatment of infertility among individuals and couples?Summary answerThe World Health Organization (WHO) made 40 recommendations and six good practice statements for the preve…

other 2025
Fertility and sterility ·doi:10.1016/j.fertnstert.2024.10.001

OBJECTIVE: To assess the adequate ovarian follicular development and oocyte recovery between ovarian potential (antral follicle count [AFC]) before the start of ovarian stimulation (OS) and oocyte quantity and quality at oocyte retrieval. A…

2024
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1470608
2024
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-024-03296-2

PurposeThe purpose of this study is to investigate the impact of daily follicle-stimulating-hormone (FSH) dose on the likelihood of suboptimal response to ovarian stimulation (OS) for in vitro fertilization (IVF) according to POSEIDON's cri…

other 2024
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-024-01291-x

BACKGROUND: Currently, there is no consensus on the optimal management of women with low prognosis in ART. In this Delphi consensus, a panel of international experts provided real-world clinical perspectives on a series of literature-suppor…

2024
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-024-03050-8

PurposeTo determine the risk of not being a poor responder in ovarian stimulation (OS) for in vitro fertilization (IVF) when ovarian reserve markers are discordant-one falling within Poseidon's criteria normal range (e.g., anti-Müllerian ho…

2023
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-023-01136-z

BackgroundIn a true-natural cycle (t-NC), optimal progesterone (P4) output from the corpus luteum is crucial for establishing and maintaining an intrauterine pregnancy. In a previous retrospective study, low P4 levels (< 10 ng/mL) measured …

review 2023
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2022.102301

A high ovarian response to conventional ovarian stimulation (OS) is characterized by an increased number of follicles and/or oocytes compared with a normal response (10-15 oocytes retrieved). According to current definitions, a high respons…

2021
The world journal of men's health ·doi:10.5534/wjmh.210025

PurposeThe use of antioxidants is common practice in the management of infertile patients. However, there are no established guidelines by professional societies on antioxidant use for male infertility.Materials and methodsUsing an online s…

2021
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deab152

Study questionWhat is the cumulative delivery rate (CDR) per aspiration IVF/ICSI cycle in low-prognosis patients as defined by the Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number (POSEIDON) criteria?Summary answerThe C…

2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.630550

ObjectiveTo estimate the prevalence of low-prognosis patients according to the POSEIDON criteria using real-world data.DesignMulticenter population-based cohort study.SettingsFertility clinics in Brazil, Turkey, and Vietnam.PatientsInfertil…

2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.688237

Despite the worldwide increase in frozen embryo transfer, the search for the best protocol to prime endometrium continues. Well-designed trials comparing various frozen embryo transfer protocols in terms of live birth rates, maternal, obste…

2020
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-020-00605-z

The prolonged lockdown of health services providing high-complexity fertility treatments -as currently recommended by many reproductive medicine entities- is detrimental for society as a whole, and infertility patients in particular. Global…

2020
Annals of translational medicine ·doi:10.21037/atm-20-2070
2020
Therapeutic advances in reproductive health ·doi:10.1177/2633494120941480

Despite the considerate progress to which assisted reproduction technology (ART) has been subject since 1978, some issues remain unresolved. Notably, the clinical management of patients with a poor ovarian response is still a challenge in e…

2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00099

The POSEIDON group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) has introduced "the ability to retrieve the number of oocytes needed to achieve at least one euploid embryo for transfer" as an intermediate marker o…

review 2019
Panminerva medica ·doi:10.23736/S0031-0808.18.03492-4

Over the years concerns have arisen about possible adverse effects associated with controlled ovarian stimulation (COS) as regards not only the endometrium, but also on obstetrical and perinatal outcomes in pregnancies after fresh embryo tr…

2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00917

This multicenter study evaluated the reliability of the recently published ART calculator for predicting the minimum number of metaphase II (MII) oocytes (MIImin) to obtain at least one euploid blastocyst in patients undergoing in vitro fer…

book 2011
·doi:10.1017/cbo9780511734755

Human Assisted Reproductive Technology: Future Trends in Laboratory and Clinical Practice offers a collection of concise, practical review articles on cutting-edge topics within reproductive medicine. Each article presents a balanced view o…